Gsk GSK
NYSE GSK
$52.42 +0.46 (+0.89%)
As of: Aug 21, 2026 · 3:59 PM EDT

Gsk (GSK) Operating Margin (2009 - 2026)

Gsk (GSK) posted quarterly Operating Margin of 5.72% for Q2 2026, down 1961.0% year-over-year from 0.31% in Q2 2025, and down 80.97% quarter-over-quarter from 30.06% in Q1 2026.

Gsk (GSK) Operating Margin (2009 - 2026) Analysis & Trends

Gsk's Operating Margin history runs 18 years deep, the most recent figure standing at 5.72% for Q2 2026.

  • In Q2 2026, Operating Margin fell 1961.0% year-over-year to 5.72%; the TTM figure through Jun 2026 stood at 23.97% (up 448.0% YoY), while the FY2025 annual figure was 24.28%, up 1147.0% from the prior year.
  • Operating Margin for Q2 2026 stood at 5.72%, down from 30.06% in the prior quarter.
  • The five-year high for Operating Margin was 31.89% in Q1 2022, with the low at 2.36% in Q3 2024.
  • The 5-year median for Operating Margin is 24.63% (2025), against an average of 22.92%.
  • The sharpest annual moves came in 2024 and 2025: Operating Margin sank 2156 bps in 2024, then jumped 2798 bps in 2025.
  • Gsk's Operating Margin stood at 23.9% in 2022, then gained by 25 bps to 29.89% in 2023, then slumped by 31 bps to 20.57% in 2024, then soared by 33 bps to 27.34% in 2025, then plunged by 79 bps to 5.72% in 2026.
  • Business Quant data shows GSK's Operating Margin at 5.72% in Q2 2026, 30.06% in Q1 2026, and 27.34% in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn 28.21%
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn 37.86%
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn -3.52%
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn 32.97%
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn 20.57%
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn 34.95%
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn -133.21%
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn 28.37%
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn 5.72%
10 Sanofi 55.07 Bn 47.69 Bn 10.79 Bn 124.39%

Historic Data

Download Data
DateValue
Jun 30, 2026 5.72%
Mar 31, 2026 30.06%
Dec 31, 2025 27.34%
Sep 30, 2025 30.34%
Jun 30, 2025 25.33%
Mar 31, 2025 29.48%
Dec 31, 2024 20.57%
Sep 30, 2024 2.36%
Jun 30, 2024 20.88%
Mar 31, 2024 20.24%
Dec 31, 2023 29.89%
Sep 30, 2023 23.92%
Jun 30, 2023 29.83%
Mar 31, 2023 29.95%
Dec 31, 2022 23.90%
Sep 30, 2022 15.21%
Jun 30, 2022 15.60%
Mar 31, 2022 31.89%
Dec 31, 2021 10.06%
Sep 30, 2021 20.82%